Massachusetts · 194th Legislature (2025-2026) · Proposed Bill
SD 2517: An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SD 2517 is a proposed bill introduced in the Massachusetts Senate on February 27, 2025. According to its official title, it concerns: An Act to promote transparency and prevent price gouging of pharmaceutical drug prices. Primary sponsor: Mark Montigny (Democratic). Most recent recorded action (February 27, 2025): House concurred.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Mr. Montigny, a petition (accompanied by bill, Senate, No. 895) of Mark C. Montigny for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Mark Montigny | Primary sponsor | Democratic | Senate | Second Bristol and Plymouth |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- House concurred
- Referred to the committee on Health Care Financing